Sign In
Buy CVAC
$4.66
+0 (+0%)
At Close: Apr 02, 2026
CureVac Shares Increase Over 8% Pre-Market: Why It Happened
08:02am, Monday, 16'th Aug 2021
The shares of CureVac N.V. (Nasdaq: CVAC) increased by over 8% pre-market.
Can CureVac Win Market Share With Only 48% Vaccine Efficacy?
06:00am, Saturday, 10'th Jul 2021
CureVac aims to become one of Europe's big suppliers.
Here's Why You Should Avoid CureVac Stock Like the Plague
07:31am, Sunday, 04'th Jul 2021
Funds will not be safe if invested in this coronavirus stock.
Is CureVac a Bargain Bet on mRNA Vaccine Technology?
06:00am, Sunday, 04'th Jul 2021
CureVac shares have slipped more than 20% on bad news.
Can CureVac Recover After Its Vaccine Setback?
06:15am, Saturday, 03'rd Jul 2021
Investors' dreams of a third strong mRNA vaccine may be over.
CureVac (CVAC) Announces Final Analysis of its COVID-19 Vaccine Study
12:02pm, Thursday, 01'st Jul 2021
CureVac (CVAC) announces final analysis from its HERALD study on CVnCoV showing efficacy of 48%.
CureVac to 'plow forward' with Covid vaccine despite disappointing results
06:57am, Thursday, 01'st Jul 2021
CureVac plans to continue work on its Covid-19 vaccine despite disappointing clinical trial results that showed the shot is just 48% effective.
CureVac Stock Drops After Final Results Confirm Its COVID-19 Vaccine Trails Rivals
05:52am, Thursday, 01'st Jul 2021
The German biotech company CureVac BV (NASDAQ: CVAC) announced on Wednesday after hours the final results of its late-stage COVID-19 vaccine trial showing 48% effectiveness at preventing the disea
Why Shares Of CureVac Are Trading Higher On Wednesday
11:18am, Wednesday, 30'th Jun 2021
CureVac (NASDAQ: CVAC) shares are trading higher after the company announced the appointment of Dr. Malte Greune as COO and the transition of Dr. Florian von der Mülbe to lead accelerated development
Without a Coronavirus Vaccine Of Its Own, Is There Any Hope For CureVac Stock?
07:19am, Tuesday, 29'th Jun 2021
Things are looking bleak right now, but they might improve with enough time.
Why CureVac Shares Are Trading Lower Today
01:34pm, Wednesday, 23'rd Jun 2021
CureVac BV (NASDAQ:CVAC) shares are trading lower by 3.6% at $56 after the CDC said preliminary findings suggest the observed reports of heart inflammation after mRNA COVID-19 vaccines are greater tha
Could CureVac Be a Millionaire-Maker Stock?
06:00am, Wednesday, 23'rd Jun 2021
CureVac's first COVID vaccine candidate disappointed investors. But a second one looks promising.
How Pfizer and Moderna Could Profit Big-Time From AstraZeneca's and CureVac's Challenges
05:55am, Wednesday, 23'rd Jun 2021
Bad news for AstraZeneca and CureVac should mean more good news for Pfizer and Moderna.
Germany's BaFin looking into possible insider trading of CureVac shares
07:29am, Monday, 21'st Jun 2021
German financial watchdog BaFin is investigating possible insider trading of vaccine maker's CureVac shares, which fell after the biotech firm announced its COVID-19 vaccine proved only 47% effective,
Why Is Everyone Talking About CureVac Stock?
06:13am, Monday, 21'st Jun 2021
This coronavirus vaccine developer just hit a massive stumbling block.
